Rayonier Advanced Materials Q3 sales and EBITDA miss estimates on tariffs, impairments

What happened

Rayonier Advanced Materials said preliminary third-quarter net sales and adjusted EBITDA both missed analyst estimates. The company reported a widened net loss from continuing operations, driven by non-cash impairments after U.S. tariffs led it to idle the Temiscaming facility.

Confirmed

Global impact / market context

Lower orders for higher-priced Cellulose Specialties shifted production toward lower-priced Cellulose Commodities, reducing the average cellulose price. Tariffs also idled Temiscaming and added costs, while higher chemical, wood, and energy expenses weighed on operating income, putting pressure on sales and earnings.

Analyst inference

The reported shortfall combines weaker product mix, tariff-related costs, and higher input expenses, while impairments widened the net loss without representing a current cash payment. The company says Temiscaming remains idle and is evaluating site options, leaving production and earnings uncertain.

Analyst inference

What to watch

1. Watch whether the company concludes its strategic review in Q1 2027 and what site options it selects for Temiscaming, which remains idle due to U.S. tariffs. Confirmed
2. Track whether Cellulose Specialties orders recover and the company shifts production back toward them; stronger sales of this higher-priced product could improve average realized cellulose prices. Analyst inference
3. Check whether tariffs and higher chemical, wood, and energy costs persist in later results, since continued pressure could weigh on operating income and cash available. Analyst inference

Evidence

• Original source link unavailable